上交所：上半年沪市集成电路公司净利润合计189.43亿元，同比增长57%

Group 1 - The core viewpoint is that the integrated circuit and biopharmaceutical industries in the Shanghai market are becoming new engines of performance growth, supported by the Sci-Tech Innovation Board [1] - The number of integrated circuit companies has increased to 138, covering the entire industry chain including design, manufacturing, and testing [1] - In the first half of the year, the total operating revenue of integrated circuit companies reached 246.675 billion yuan, with a net profit of 18.943 billion yuan, representing year-on-year growth of 14% and 57% respectively [1] - Biopharmaceutical companies achieved a total revenue of 251.109 billion yuan and a net profit of 31.862 billion yuan, with year-on-year growth of 1% and 14% respectively [1] - The Sci-Tech Innovation Board has become a major platform for biopharmaceutical companies to go public globally, following the United States and Hong Kong [1]